Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.

Trial Profile

Phase I Dose Finding Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide for Subjects With Solid Tumor Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jan 2016

At a glance

  • Drugs Carboplatin; Paclitaxel; Temozolomide
  • Indications Small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jan 2016 Trial focus changed from Therapeutic use and Adverse events to only Adverse events:- Overall tumor response rate removed from primary endpoint as per ClinicalTrials.gov. record.
    • 19 Sep 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 19 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top